Log in

Relevant bibliographies by topics / Invasive ductal breast carcinoma non special type

Contents

Journal articles
Book chapters
Conference papers

Academic literature on the topic 'Invasive ductal breast carcinoma non special type'

Author: Grafiati

Published: 5 June 2025

Last updated: 16 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Invasive ductal breast carcinoma non special type.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Invasive ductal breast carcinoma non special type"

1

Ioannis, Manolis, Kafiri Georgia, Venetikou Maria, Thalassinos Nikolaos, and Anthouli-Anagnostopoulou Fragkiski. "Prognostic factors of Invasive Ductal Breast Carcinoma Non Special Type (NST). A Study of 98 cases." REVIEW CLINICAL PHARMACOLOGY AND PHARMACOKINETICS, INTERNATIONAL EDITION 37, no. 2 (2023): 53–62. https://doi.org/10.5281/zenodo.8337644.

Full text

Abstract:

<em>Prognostic factors of histological subtypes in breast cancer, is still not well established, guidelines based on the histological subtype alone. The decisions for therapy are guided mostly independently of the histological subtype and are also guided by biomarkers and tumor stage. We analyzed a special histological subtype, Invasive Ductal Breast Carcinoma Non Special Type and correlated with patient’s age, tumor grade, comedo type necrosis, necrosis, ER and PR receptors, Ki67 expression, HER2 status, pT tumor stage, pN lymph nodes stage, TNM classification and clinical tumor stage,

APA, Harvard, Vancouver, ISO, and other styles

2

Aschie, Mariana, Gabriela Izabela Baltatescu, Georgeta Camelia Cozaru, Anca Mitroi, and Manuela Enciu. "Morphopathological and immunohistochemical features of a pure mucinous breast carcinoma – Case report." ARS Medica Tomitana 22, no. 3 (2016): 174–80. http://dx.doi.org/10.1515/arsm-2016-0029.

Full text

Abstract:

AbstractPure mucinous carcinoma is a rare special type of breast carcinoma with a 2% incidence and it is usualy asociated with a good prognosis. It must distingished from the mixed subtype of mucinos breast carcinoma, which has an invasive non-mucinous component in more than 10% of the tumor and change the favourable outcome of the first subtype. In this report we present a case of a premenopausal woman with a lump in right breast wich histopathologically proved to be a pure mucinous carcinoma associated with high grade ductal carcinoma in situ. Immunohistochemical and ancillary studies demons

APA, Harvard, Vancouver, ISO, and other styles

3

Nakagawa, Tsuyoshi, Goshi Oda, Hiroki Mori, et al. "Prognosis of Subcutaneous Mastectomy for Special Types of Breast Cancer." Medicina 58, no. 1 (2022): 112. http://dx.doi.org/10.3390/medicina58010112.

Full text

Abstract:

Background and objectives: In the treatment of the special type of breast cancer (STBC), the choice of chemotherapeutic agents is often based on the characteristic features of the histological type. On the other hand, the surgical strategy is usually determined by the tumor size and presence of lymph node metastasis, and the indication for immediate reconstruction is rarely discussed based on the histological type. The prognoses of STBC and invasive ductal carcinoma of the breast (IDC) patients who underwent subcutaneous mastectomy (SCM) with immediate reconstruction at our institution were co

APA, Harvard, Vancouver, ISO, and other styles

4

Ameer, Amna, Farhan Akhtar, Hafeez Ud Din, and Rabia Ahmad. "IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI." PAFMJ 71, no. 1 (2021): 7–11. http://dx.doi.org/10.51253/pafmj.v71i1.4687.

Full text

Abstract:

Objective: To determine the frequency of immunohistochemical expression of androgen receptor in triplenegative breast carcinoma. Study Design: Cross sectional study. Duration and Place of Study: This study included 30 cases confirmed as triple negative breast carcinoma atArmed Forces Institute of Pathology Rawalpindi, from Jan to Jul 2018. Methodology: Anti-androgen receptor antibody was applied and assessed. Positive expression was defined asgreater and equal to 10% nuclear immunostaining. SPSS-24 was used for analyzing data. Results: Out of 30 cases of triple negative

APA, Harvard, Vancouver, ISO, and other styles

5

Sayed, S., Z. Moloo, S. Mukono, et al. "Pathologic characteristics of breast cancer with special emphasis on prevalence of triple-negative breast cancer from Kenya: A 4-year experience." Journal of Clinical Oncology 29, no. 27_suppl (2011): 35. http://dx.doi.org/10.1200/jco.2011.29.27_suppl.35.

Full text

Abstract:

35 Background: Previous sub classification of breast cancer in Kenya has been fraught by small sample size, non uniform staining methodology and lack of independent review. Triple Negative Breast Cancer (TNBC) is a “special interest” cancer since it represents a significant proportion of breast cancer patients and is associated with a poorer prognosis. We aimed to determine the estrogen receptor (ER), progesterone receptor (PR) and Her2/neu receptor characteristics of breast cancers and the prevalence of TNBC diagnosed at Aga Khan University Hospital, Nairobi (AKUHN) between 2007 to date. Meth

APA, Harvard, Vancouver, ISO, and other styles

6

de Faria Castro Fleury, Eduardo, Caio Castro, Mario Sergio Campos do Amaral, and Décio Roveda Junior. "Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy." Breast Cancer: Basic and Clinical Research 16 (January 2022): 117822342210958. http://dx.doi.org/10.1177/11782234221095897.

Full text

Abstract:

Rationale and Objectives: According to the Breast Imaging and Reporting Data System (BI-RADS), one of the main limitations of MRI is diagnosing the non-mass enhancement (NME). The NME lesion is challenging since it is unique to the MRI lexicon. This study aims to report our experience with NME lesions diagnosed by MRI referred for MRI-guided biopsies and discuss the management and follow-up of these lesions. Materials and Methods: We retrospectively evaluated all MRI-guide breast biopsies. We included all patients referred for NME breast MRI-guided biopsy in screening settings. All patients ha

APA, Harvard, Vancouver, ISO, and other styles

7

Manish, Kumar Jha, Imteyaz Alam Md., Bharti Madhu, and Kumari Poonam. "A Hospital Based Observational Assessment of the Histopathology of Benign Proliferative Breast Lesions in Peritumoral Area of Carcinoma Breast." International Journal of Current Pharmaceutical Review and Research 15, no. 08 (2023): 144–48. https://doi.org/10.5281/zenodo.12543741.

Full text

Abstract:

AbstractAim: The aim of the study was to determine histopathological features of different subtypes of carcinoma breastand correlate with the presence of proliferative lesions of breast in peritumoral area.Methods: This Observational study was conducted for a period of 1 year at department of Pathology,Darbhanga Medical College and Hospital, Darbhanga, Bihar, India and A total of 100 cases that satisfied theinclusion criteria were included in this study. Specimens were received in 10% Formalin. Clinical details, grossfindings including tumor size were noted.Results: Age group of patients inclu

APA, Harvard, Vancouver, ISO, and other styles

8

Putri, Helenia, Maria A. Kristina, Devita Widjaja, Bernard A. Baskoro, Erna Kristiani, and Rusli Muljadi. "Distributions of Breast Cancer Primary Tumor Locations in Indonesian Patients." Medicinus 9, no. 3 (2023): 86. http://dx.doi.org/10.19166/med.v9i3.6970.

Full text

Abstract:

<p><strong>Introduction:</strong> Overseas studies have shown various distributions of breast cancer primary tumor locations based on stages and histopathologic types. Based on them, breast cancer was consistently reported to be found on theleft breast more than the right. Breast cancer laterality was estimated to be one of the determinant factors in prognosis. In Indonesia, there are only a few studies on the laterality of breast cancer, as well as the characteristics that accompany it. The aim of this study is to know the distributions of primary breast cancer tumor locatio

APA, Harvard, Vancouver, ISO, and other styles

9

Imoto, S., S. Morita, M. Kitajima, T. Aikou, and Y. Kitagawa. "Early recurrence of breast cancer after sentinel node navigation surgery: A multicenter prospective study in Japan." Journal of Clinical Oncology 27, no. 15_suppl (2009): e11530-e11530. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e11530.

Full text

Abstract:

e11530 Background: To assess lymphatic mapping technique and prognosis after sentinel node navigation surgery (SNNS), the Japanese society for SNNS conducted a non-randomized multi-center prospective study on SNNS in early breast cancer. Primary endpoint is to evaluate the success rate and adverse events of SNNS, and secondary endpoint is to observe the outcome of patients who underwent SNNS during 5 years. Methods: We demonstrated the results of primary endpoint at 2007 ASCO annual meeting (#606). Fourteen hundred and sixty-eight cases had pre-registration from 65 investigators at 23 institut

APA, Harvard, Vancouver, ISO, and other styles

10

Yamanaka, Taro, Tatsunori Shimoi, Mai Onishi, et al. "Abstract P3-05-24: Mapping the Genomic Landscape: Comprehensive Profiling of Diverse Histological Types of Breast Cancer." Clinical Cancer Research 31, no. 12_Supplement (2025): P3–05–24—P3–05–24. https://doi.org/10.1158/1557-3265.sabcs24-p3-05-24.

Full text

Abstract:

Abstract Introduction: Breast Cancer (BC) is a highly heterogeneous tumor consisting of various histological types. Data on genomic alterations (GAs) in special types of breast cancer, which account for about 10% of all breast cancers, remain limited. We aimed to clarify genomic profiles of BC, especially focusing on breast cancer of special type. Methods: We retrospectively reviewed data on female patients with unserectable/metastatic BC who underwent comprehensive genomic profiling (CGP) tests and were registered for the Center for Cancer Genomics and Advanced Therapeutics in Japan from June

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Invasive ductal breast carcinoma non special type"

1

Wu, Yun, Sandra J. Shin, and Aysegul A. Sahin. "Special Histologic Types and Special Morphologic Patterns of Invasive Ductal Carcinoma of No Special Type: Mucinous, Micropapillary, Mucinous Cystadenocarcinoma, Neuroendocrine Neoplasm, Cystic Hypersecretory, Glycogen-Rich Clear Cell, Carcinoma with Osteoclast-Like Giant Cells." In A Comprehensive Guide to Core Needle Biopsies of the Breast. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-05532-4_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hicks, David G., and Susan C. Lester. "Invasive Ductal Carcinoma (Adenocarcinomas of No Special Type)." In Diagnostic Pathology: Breast. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-323-37712-6.50041-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Rakha, Emad A., and Ian Ellis. "Invasive Ductal Carcinoma of No Special Type and Histologic Grade." In Breast Pathology. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-323-38961-7.00023-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rakha, Emad A., and Ian O. Ellis. "Invasive Ductal Carcinoma of No Special Type and Histologic Grade." In Breast Pathology. Elsevier, 2012. http://dx.doi.org/10.1016/b978-1-4377-0604-8.00023-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Invasive ductal breast carcinoma non special type"

1

Belluco, Rosana Zabulon Feijó, Carolina Gaze Gonçalves Fontenele Gomes, Camila Pires Marinho, et al. "Breast neoplasm with distinct histological subtypes: A case report." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1048.

Full text

Abstract:

Introduction: Breast cancer is a heterogeneous disease, divided into many subtypes, the most common being invasive ductal. Breast tumors can be derived from epithelial tissue or mesenchymal cells. Most malignant breast tumors are made up of a single type of tumor. Cases where there are two or more types of malignant tumors occurring at the same time are rare. We report a case with different types of malignancies, i.e., non-special invasive ductal carcinoma, metaplastic carcinoma, and squamous cell carcinoma occurred together. Case report: A woman, 56 years old, with no family history of gyneco

APA, Harvard, Vancouver, ISO, and other styles

2

Belluco, Rosana Zabulon Feijó, Carolina Gaze Gonçalves Fontenele Gomes, Paulo Eduardo Silva Belluco, et al. "LOCALLY ADVANCED SYNCHRONOUS BILATERAL BREAST CANCER: A RARE CASE REPORT." In Brazilian Breast Cancer Symposium 2022. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s2083.

Full text

Abstract:

Introduction: Synchronous bilateral breast cancer (SBBC) consists of the simultaneous presence of two primary tumors at diagnosis. There is no consensus on its origin, and it may be a metastasis of a primary lesion or a second independent tumor. The incidence of SBBC has been reported to be approximately 3%. The prognosis of SBBC was considered to be reserved, which is why bilateral mastectomy is the preferred approach. Case report: A 44-year-old patient with no family record of gynecological neoplasm sought care reporting bilateral breast pain and palpable nodular lesions on the breasts. On e

APA, Harvard, Vancouver, ISO, and other styles

3

Queiroz, Andrei Alves de, Debora Garcia y. Narvaiza, Ana Maria Kemp, and Gisele Tolaini Gomes Pereira. "LOBULAR BREAST CARCINOMA: THE RISK FOR CONTRALATERAL BREAST IS NOT PERMANENT." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1028.

Full text

Abstract:

Introduction: The invasive lobular carcinoma of the breast occurs in approximately 10% of breast cancers. The increased risk for multicentric and bilateral breast tumor is well-documented in the literature, but few data is available regarding the interval for occurrence of contralateral tumors. Objectives: This study aims to analyze the characteristics of the bilaterality of the lobular tumor and time to the occurrence of the bilateral tumor in comparison with non-lobular tumors. Methods: Retrospective, analytical study from the American Surveillance, Epidemiology and End Results Program (SEER

APA, Harvard, Vancouver, ISO, and other styles

4

Sousa, Andrea Alves da Silva de, Rocio Fernandez Santos Viniegra, Francisco Gabriel da Silva Frederico, and Peterson Tiago Galvão. "SYNCHRONOUS BILATERAL CARCINOMA IN SITU: A CASE REPORT." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1009.

Full text

Abstract:

Synchronous bilateral breast carcinoma (SBBC) is defined as the simultaneous presence of two primary tumors at diagnosis, one in each breast. It is also considered synchronous when the ipsilateral cancer is diagnosed within 12 months of the first diagnosis. No consensus has been reached on the origin of SBBC, as it can be interpreted as either a metastasis or a new primary tumor, and its prognosis is controversial. As this tumor is rare and requires further investigation, this study aims to report the case of a patient with SBBC with different biological characteristics. A woman, 63 years old,

APA, Harvard, Vancouver, ISO, and other styles

5

Oliveira, Leandro Gonçalves, Ana Cláudia Gonçalves Lima, Sebastião Alves Pinto, Barbara Elisabeth Schroff, André Maroccolo de Sousa, and Juarez Antônio de Sousa. "BREAST CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS: A CASE REPORT." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2052.

Full text

Abstract:

Introduction: Breast carcinoma with osteoclastic giant cells (OGCs) is rare. According to the WHO classification, breast tumors are designated “carcinoma with osteoclast-like giant cells” and are categorized under invasive carcinoma of no special type. This distinct subtype of breast carcinoma was first described in the French medical literature by Leroux in 1931 and Duboucher et al. in 1933. We reported a case study of a woman with OGCs with an invasive ductal and papillary carcinoma. Case Presentation: A 69-year-old female presented with left-sided breast lump. Ultrasound study documented th

APA, Harvard, Vancouver, ISO, and other styles

6

Ramos, Marcellus Nascimento Moreira, Andressa Gonçalves Amorim, Andre Mattar, Luis Henrique Gebrim, and Mariana Dinau Leal Passos. "CLINICAL, IMAGING AND THERAPEUTIC CHARACTERISTICS OF 332 PATIENTS WITH DUCTAL CARCINOMA IN SITU (DCIS): A SINGLE‑ CENTER ANALYSIS." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1063.

Full text

Abstract:

Introduction: Organized mammographic screening led to an increase in the diagnosis of DCIS. In countries with adequate mammographic coverage, the percentage of DCIS reaches 20%. In Brazi, most of the states only perform occasional mammographic screening, and data about DCIS incidence is scarce. Objectives: Analyze and describe clinical, diagnostic, imaging and therapeutic characteristics of patients diagnosed with DCIS and treated at Pérola Byington Hospital (PBH), Brazil. Methods: The official database of PBH from January 2011 to December 2019 showed 11,373 cases of breast cancer, and 812 (7.

APA, Harvard, Vancouver, ISO, and other styles

7

Goi, Mariana Copetti, Ana Paula Santana de z. Abreu, Sheila Cristina Lordelo Wludarski, Joaquim Teodoro de Araújo Neto, and Edison Mantovani Barbosa. "Primary breast lymphoma associated with invasive breast carcinoma: a case report." In XXVI Brazilian Mastology Congress. Mastology, 2024. https://doi.org/10.29289/259453942024v34s2039.

Full text

Abstract:

Introduction: This case report describes a 54-year-old patient who developed invasive breast carcinoma in her left breast without further specifications, of the luminal B molecular subtype, concurrently with a primary breast lymphoma (diffuse large B-cell lymphoma with the germinal center B-cell subtype), which was definitively diagnosed only after surgical intervention. Synchronous occurrence of breast cancer and non-Hodgkin lymphoma (NHL) is an uncommon situation, with only 38 cases reported in the literature. It is extremely rare for both tumors to present as a collision tumor within the sa

APA, Harvard, Vancouver, ISO, and other styles

8

Carvalho, Débora Medeiros de, Josielly Ferreira Bacelar, Joarla Ayres de Morais Estevão, et al. "Survival analysis of patients with 10 or more axillary lymph nodes compromised by breast cancer." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1085.

Full text

Abstract:

Objective: The objective of this study was to evaluate survival in patients with 10 or more compromised axillary lymph nodes. Methodology: This is a retrospective cohort study conducted in a private oncology clinic in Teresina, Piauí, Brazil, in the period 1999–2023, where medical records of 12 patients with breast cancer who had 10 or more compromised axillary lymph nodes were analyzed. The following variables were observed: patient age, histological type of tumor, tumor size, lymphatic invasion, vascular invasion, perineural invasion, number of lymph nodes dissected, number of axillary lymph

APA, Harvard, Vancouver, ISO, and other styles

9

Chielle, EO, and EL Kuiava. "METHOD OF HISTOPATHOLOGICAL DIAGNOSIS OF MAMMARY NODULES THROUGH DEEP LEARNING ALGORITHM." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.5491.

Full text

Abstract:

Objective: Artificial intelligence systems are promising health care technologies, mainly in medical subareas such as pathology, and can be used as support methods for the histological pathogenesis of mammary nodules. This study describes the method and results of the development of an artificial intelligence software for the histopathological analysis of mammary nodules. Method: The software was developed by using two neural networks – inception and MobileNet. The database used for learning the conditions analyzed – histologically normal breast, fibroadenoma, fibrocystic changes, in situ duct

APA, Harvard, Vancouver, ISO, and other styles

10

Couto, Henrique Lima, Carolina Nazareth Valadares, Aleida Nazareth Soares, Bernardo Ferreira de Paula Ricardo, and Vivian Resende. "Vacuum-assisted biopsy as a diagnosis of low-risk ductal carcinoma in situ (DCIS) with progression potential and subsequent active surveillance." In XXVI Brazilian Mastology Congress. Mastology, 2024. https://doi.org/10.29289/259453942024v34s2021.

Full text

Abstract:

Introduction: The treatment of breast cancer has evolved from radicalization and broad application — such as radical mastectomy for all cases — to personalized and de-escalation approaches, targeted therapies, and conservative surgery. Likewise, the diagnosis of breast cancer has progressed from diagnostic surgery and incisional biopsies to minimally invasive percutaneous procedures, fine-needle aspiration biopsy (FNAB), and core biopsies. Accurate histological diagnosis is a prerequisite for proper therapeutic planning, aiming to achieve optimal disease control with minimal aesthetic and func

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!